ACHV
ACHV
NASDAQ · Biotechnology

Achieve Life Sciences Inc

$3.17
+0.23 (+7.82%)
As of Apr 1, 2:30 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +906.0% upside
Low Target $22.93
Average Target $31.89
High Target $41.27
Current Price $3.17
Current
$3.17
Target
$31.89
$22.93 $31.89 avg $41.27
Scenario Analysis
Bear Case
$22.93
623.3%
Low target
Base Case
$31.89
+906.0%
Avg target
Bull Case
$41.27
+1,201.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$6.03
-47.4% from high
52-Week Low
$1.84
+72.3% from low
Target vs 52W High
$31.89
+429.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%